166 related articles for article (PubMed ID: 37894942)
1. CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.
Lee CC; Tsai KY; Lee AW; Wei PL; Huang CY; Batzorig U; Chang YJ
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894942
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
[TBL] [Abstract][Full Text] [Related]
3. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of
Tsai YM; Wu KL; Chang YY; Hung JY; Chang WA; Chang CY; Jian SF; Tsai PH; Huang YC; Chong IW; Hsu YL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121246
[TBL] [Abstract][Full Text] [Related]
5. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
6. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
8. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
9. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
[No Abstract] [Full Text] [Related]
10. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
[TBL] [Abstract][Full Text] [Related]
11. Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression
Wang XD; Lu J; Lin YS; Gao C; Qi F
World J Gastroenterol; 2019 Apr; 25(14):1697-1714. PubMed ID: 31011255
[TBL] [Abstract][Full Text] [Related]
12. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
Chang S; Sun G; Zhang D; Li Q; Qian H
Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
14. Long non‑coding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
Ai X; Lei Q; Shen X; Li J; Cen C; Xie G; Luo B; Zhu W; Hu G; Wu H; Chen M; Li X; Lin C
Oncol Rep; 2019 Jan; 41(1):483-491. PubMed ID: 30542703
[TBL] [Abstract][Full Text] [Related]
15. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer.
Kim SL; Lee ST; Min IS; Park YR; Lee JH; Kim DG; Kim SW
Cancer Sci; 2017 Nov; 108(11):2176-2186. PubMed ID: 28859238
[TBL] [Abstract][Full Text] [Related]
18. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
19. TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer.
Ma JJ; Xiang C; Wang JW
Aging (Albany NY); 2023 Oct; 15(19):10607-10626. PubMed ID: 37815894
[TBL] [Abstract][Full Text] [Related]
20. mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis.
Cheng X; Shen T; Liu P; Fang S; Yang Z; Li Y; Dong J
BMC Cancer; 2022 Nov; 22(1):1151. PubMed ID: 36348305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
